Xilis

About:

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Website: http://www.xilis.net

Twitter/X: Xilis_Inc

Top Investors: Alexandria Venture Investments, Pear VC, 8VC, Google Ventures, KdT Ventures

Description:

Xilis is a biotechnology company that develops technologies to guide precision therapy for cancer patients and accelerate drug discovery. The company's platform enables diagnostics, drug screening, and scalable patient-derived models for drug discovery, enabling physicians and pharmaceutical companies to develop tailored treatments for patients by conducting drug screening.

Total Funding Amount:

$92M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)xilis.net

Founders:

David Hsu, Hans Clevers, Xiling Shen

Number of Employees:

51-100

Last Funding Date:

2022-07-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai